参考文献：
1.《中国银屑病诊疗指南（2023版）》
2.中华医学会皮肤性病学分会银屑病专业委员会. 中国银屑病诊疗指南（2023版） [J] . 中华皮肤科杂志, 2023, 56(7) : 573-625. DOI: 10.35541/cjd.20220839
3.Yan K, Li F, Bi X, Han L, et al. Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trial. J Am Acad Dermatol. 2024 Sep 26:S0190-9622(24)02887-1.
4.Xu Jinhua, et al. Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: a randomized, doubleblind, placebo-controlled phase 3 trial. 2023 EADV. Abstract N°: 115.
来源：生命时报
网编：师涛
